Accurate diagnosis and assessment of infectious agent-associated lymphoproliferations can be challenging due to overlapping clinicopathologic features among reactive changes, borderline conditions, and lymphomas, as well as various subtypes of lymphomas.  The Joint CSHP and SH Workshop 2019 will focus on narrowing practice gap in management of infectious agent-associated lymphoproliferations (IALP) by addressing pragmatic difficulties in the diagnosis of these conditions through meeting its learning objectives.

Learning Objectives

The Workshop will focus on the following goals and overarching objectives:

1). Illustrate overlapping features and diagnostic challenges of IALP, including borderline conditions between reactive lymphoproliferations and lymphomas, as well as various subtypes of infectious agent-associated lymphomas;
2). Elucidate and expand the diagnostic criteria set by the current WHO classification systems;
3). Recognize host susceptibility factors including molecular markers in the development and progression of IALP;
4). Develop consensus recommendations in approaches of distinguishing highly aggressive IALP from indolent forms, including conditions related to chronic active EBV infections.
Program (please refer to the PROGRAM Section of the Workshop website)

Accreditation Information

Intended Audience
Hematopathologists, Hematologist, dermatopathologists, dermatologists, oncologists, general pathologists, and pathologists of other subspecialties.

Physician Accreditation Statement
Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety.  You must participate in the entire activity as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.


In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society for Hematopathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 11.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

  • DAYS
Key Dates
    October 19-20, 2019
    Online Registration Deadline
    September 1, 2019
    On-site Registration Dates
    October 18, 2019
    Case submission and registration open
    March 1, 2019
    Case submission close
    July 5, 2019
    Notifications of the selected cases
    August 19, 2019